No description available.

Contexte: Les bénéfices associés à l’utilisation de sujets cadavériques en enseignement médical sont bien documentés et la maîtrise des dernières techniques endovasculaires est essentielle à la pratique quotidienne des chirurgiens vasculaires. Notre étude démontre la faisabilité d’élaborer un modèle cadavérique humain avec perfusion artério-veineuse antérograde pulsatile et chauffée pour une simulation endovasculaire fiable et reproductible. Méthodes: La canulation de sept sujets cadavériques conservés en solution saturée en sel a été réalisée pour permettre une perfusion centrale gauche-droite avec une solution chauffée, de l’aorte ascendante vers l’oreillette droite. Pour ce faire, nous avons utilisé des fistules artério-veineuses carotido-jugulaire et fémoro-fémorale créées chirurgicalement. Une pulsatilité de plus de 4.5 litres par minutes a été atteinte grâce à un prototype de pompe abordable conçue par des ingénieurs biomédicaux. La pression artérielle invasive et la température étaient contrôlées. Des séances de formation pour des procédures endovasculaires aortiques et des manipulations chirurgicales ouvertes ont été réalisées avec ce modèle. Résultats: Une perfusion cadavérique efficace a été possible pendant plusieurs heures, non seulement par voie artério-artérielle mais aussi avec une circulation artério-veineuse. La pression artérielle et les températures in situ ont reproduit fidèlement les fonctions vasculaires pour offrir des conditions similaires à la réalité. Ce nouveau modèle a permis de réaliser avec succès la mise en place d’une endoprothèse aortique thoracique (TEVAR), l’insertion d’un stent à l’artère sous-clavière gauche, et une simulation de la prise en charge chirurgicale ouverte d’une hémorragie sur traumatisme vasculaire. La méthode de conservation en solution saturée en sel et une pompe spécialement conçue ont amélioré la compétitivité des coûts. Conclusion: La simulation endovasculaire sur des sujets cadavériques, optimisée grâce au système de perfusion pulsatile et chauffé, peut être un complément dynamique à la formation chirurgicale et pour se familiariser avec de nouveaux instruments. Cet outil pédagogique reproductible pourrait trouver sa place dans tous les programmes d’enseignement chirurgical. / Abstract Background: The benefits of using cadaveric human subjects in surgical training are well documented and knowledge of the latest endovascular techniques is essential in the daily practice of vascular surgeons. Our study demonstrates the feasibility of developing an affordable human cadaveric model, with pulsatile and heated antegrade perfusion, for reliable and reproducible endovascular or surgical simulation. Methods: Cannulation of seven saturated-salt-solution embalmed human cadavers was undertaken to create a left-to-right central perfusion with a heated solution, from the ascending thoracic aorta to the right atrium. To that end, we used surgically created carotido-jugular and femoro-femoral arteriovenous fistulas. Pulsatile flow rate greater than 4.5 liters per minute was achieved with an affordable prototype pump designed by biomedical engineers. Invasive blood pressure and temperature were monitored. Training for endovascular thoracic aortic procedures and open vascular surgeries was performed using this model. Results: Effective cadaveric perfusion was achieved for several hours, not only with an arterio-arterial pathway but also with arteriovenous circulation. The arterial pressures and in situ temperatures accurately restored vascular functions for life-like conditions. This new model made it possible to successfully perform thoracic endovascular aortic repair (TEVAR), subclavian artery stenting, and simulation of abdominal open vascular trauma management. The saturated salt solution method and a specifically designed pump improved cost competitiveness. Conclusion: Endovascular simulation on human cadavers, optimized with the pulsatile and heated perfusion system, can be a dynamic adjunct for surgical training and familiarization with new devices. This reproducible teaching tool could be relevant in all surgery programs.

Purpose: To evaluate the use of the GoBack-catheter (Upstream Peripheral Technologies) in complex revascularizations in lower limb arteries. Materials and Methods: In this retrospective single-center study, the results of the first 100 consecutive patients including 101 limb-revascularizations, performed between May 2018 and July 2020 with the study device, were analyzed. In all cases, guidewire-crossing failed, and all lesions were chronic total occlusions (CTO), either de novo, reocclusions, or in-stent reocclusions. Successful crossing was defined as passing the CTO using the study device. Patency at discharge and after 30 days was defined as less than 50% restenosis on duplex sonography, without target lesion revascularization. Results: Median lesion length was 24 cm and 38 patients (37.6%) had a calcium grading according to the peripheral arterial calcium scoring system (PACSS) of 4 or 5. In 20.8% of patients, an occluded stent was treated. CTOs involved the femoropopliteal segment in 91.1%, iliac arteries in 5.9%, and tibial arteries in 7.9%. The GoBackcatheter was employed for entering into or crossing through parts or the full length of a CTO or an occluded stent as well as for re-entering into the true lumen after subintimal crossing. The device was used via contralateral and ipsilateral antegrade as well as retrograde access with an overall technical success rate of 92.1%. In 3 patients minor bleeding occurred at the crossing or re-entry site, which were managed conservatively. Thirty-day adverse limb events comprised minor amputations in 4 patients (4.0%), 1 major amputation (1.0%), and reocclusions in 7 limbs (6.9%). Conclusion: The new GoBack-catheter offers versatile endovascular applicability for complex CTO recanalization in a broad range of peripheral vascular interventions with a high technical success and low complication rate.

Background: The impact of COVID-19 on clinical outcomes in acute ischemic stroke patients receiving reperfusion therapy remains unclear. We therefore aimed to synthesize the available evidence to investigate the safety and short-term efficacy of reperfusion therapy in this patient population. Methods: We searched the electronic databases MEDLINE, Embase and Cochrane Library Reviews for randomized controlled trials and observational studies that investigated the use of intravenous thrombolysis, endovascular therapy, or a combination of both in acute ischemic stroke patients with laboratory-confirmed COVID-19, compared to controls. Our primary safety outcomes included any intracerebral hemorrhage (ICH), symptomatic ICH and all-cause in-hospital mortality. Short-term favorable functional outcomes were assessed at discharge and at 3 months. We calculated pooled risk ratios (RR) and 95% confidence intervals (CI) using DerSimonian and Laird random-effects model. Heterogeneity was evaluated using Cochran’s Q test and I2 statistics. Results: We included 11 studies with a total of 477 COVID-19 positive and 8,092 COVID-19 negative ischemic stroke patients who underwent reperfusion therapy. COVID-19 positive patients exhibited a significantly higher risk of experiencing any ICH (RR 1.54, 95% CI 1.16–2.05, p < 0.001), while the nominally increased risk of symptomatic ICH in these patients did not reach statistical significance (RR 2.04, 95% CI 0.97–4.31; p = 0.06). COVID-19 positive stroke patients also had a significantly higher in-hospital mortality compared to COVID-19 negative stroke patients (RR 2.78, 95% CI 2.15–3.59, p < 0.001). Moreover, COVID-19 positive stroke patients were less likely to achieve a favorable functional outcome at discharge (RR 0.66, 95% CI 0.51–0.86, p < 0.001) compared to COVID-19 negative patients, but this difference was not observed at 3-month follow-up (RR 0.64, 95% CI 0.14–2.91, p = 0.56). Conclusion: COVID-19 appears to have an adverse impact on acute ischemic stroke patients who undergo reperfusion therapy, leading to an elevated risk of any ICH, higher mortality and lower likelihood of favorable functional outcome.

Magnesium alloys have been widely explored as potential biomaterials, but several limitations to using these materials have prevented their widespread use, such as uncontrollable degradation kinetics which alter their mechanical properties. In an attempt to further the applicability of magnesium and its alloys for biomedical purposes, two novel magnesium alloys Mg-Zn-Cu and Mg-Zn-Se were developed with the expectation of improving upon the unfavorable qualities shown by similar magnesium based materials that have previously been explored. The overall performance of these novel magnesium alloys has been assessesed in three distinct phases of research: 1) analysing the mechanical properties of the as-cast magnesium alloys, 2) evaluating the biocompatibility of the as-cast magnesium alloys through the use of in-vitro cellular studies, and 3) profiling the degradation kinetics of the as-cast magnesium alloys through the use of electrochemical potentiodynamic polarization techqnique as well as gravimetric weight-loss methods. As compared to currently available shape memory alloys and degradable as-cast alloys, these experimental alloys possess superior as-cast mechanical properties with elongation at failure values of 12% and 13% for the Mg-Zn-Se and Mg-Zn-Se alloys, respectively. This is substantially higher than other as-cast magnesium alloys that have elongation at failure values that range from 7-10%. Biocompatibility tests revealed that both the Mg-Zn-Se and Mg-Zn-Cu alloys exhibit low cytotoxicity levels which are suitable for biomaterial applications. Gravimetric and electrochemical testing was indicative of the weight loss and initial corrosion behavior of the alloys once immersed within a simulated body fluid. The development of these novel as-cast magnesium alloys provide an advancement to the field of degradable metallic materials, while experimental results indicate their potential as cost-effective medical devices.

Le traitement chirurgical des anévrismes de l'aorte abdominale est de plus en plus remplacé par la réparation endovasculaire de l’anévrisme (« endovascular aneurysm repair », EVAR) en utilisant des endoprothèses (« stent-grafts », SGs). Cependant, l'efficacité de cette approche moins invasive est compromise par l'incidence de l'écoulement persistant dans l'anévrisme, appelé endofuites menant à une rupture d'anévrisme si elle n'est pas détectée. Par conséquent, une surveillance de longue durée par tomodensitométrie sur une base annuelle est nécessaire ce qui augmente le coût de la procédure EVAR, exposant le patient à un rayonnement ionisants et un agent de contraste néphrotoxique. Le mécanisme de rupture d'anévrisme secondaire à l'endofuite est lié à une pression du sac de l'anévrisme proche de la pression systémique. Il existe une relation entre la contraction ou l'expansion du sac et la pressurisation du sac. La pressurisation résiduelle de l'anévrisme aortique abdominale va induire une pulsation et une circulation sanguine à l'intérieur du sac empêchant ainsi la thrombose du sac et la guérison de l'anévrisme. L'élastographie vasculaire non-invasive (« non-invasive vascular elastography », NIVE) utilisant le « Lagrangian Speckle Model Estimator » (LSME) peut devenir une technique d'imagerie complémentaire pour le suivi des anévrismes après réparation endovasculaire. NIVE a la capacité de fournir des informations importantes sur l'organisation d'un thrombus dans le sac de l'anévrisme et sur la détection des endofuites. La caractérisation de l'organisation d'un thrombus n'a pas été possible dans une étude NIVE précédente. Une limitation de cette étude était l'absence d'examen tomodensitométrique comme étalon-or pour le diagnostic d'endofuites. Nous avons cherché à appliquer et optimiser la technique NIVE pour le suivi des anévrismes de l'aorte abdominale (AAA) après EVAR avec endoprothèse dans un modèle canin dans le but de détecter et caractériser les endofuites et l'organisation du thrombus. Des SGs ont été implantés dans un groupe de 18 chiens avec un anévrisme créé dans l'aorte abdominale. Des endofuites de type I ont été créés dans 4 anévrismes, de type II dans 13 anévrismes tandis qu’un anévrisme n’avait aucune endofuite. L'échographie Doppler (« Doppler ultrasound », DUS) et les examens NIVE ont été réalisés avant puis à 1 semaine, 1 mois, 3 mois et 6 mois après l’EVAR. Une angiographie, une tomodensitométrie et des coupes macroscopiques ont été réalisées au moment du sacrifice. Les valeurs de contrainte ont été calculées en utilisant l`algorithme LSME. Les régions d'endofuite, de thrombus frais (non organisé) et de thrombus solide (organisé) ont été identifiées et segmentées en comparant les résultats de la tomodensitométrie et de l’étude macroscopique. Les valeurs de contrainte dans les zones avec endofuite, thrombus frais et organisé ont été comparées. Les valeurs de contrainte étaient significativement différentes entre les zones d'endofuites, les zones de thrombus frais ou organisé et entre les zones de thrombus frais et organisé. Toutes les endofuites ont été clairement caractérisées par les examens d'élastographie. Aucune corrélation n'a été trouvée entre les valeurs de contrainte et le type d'endofuite, la pression de sac, la taille des endofuites et la taille de l'anévrisme. / Surgical treatment of abdominal aortic aneurysms is increasingly being replaced by EVAR using SGs. However, the efficacy of this less invasive approach is jeopardized by the incidence of persistent flow within the aneurysm, called endoleaks leading to aneurysm rupture if not properly detected. Hence, a life-long surveillance by computed tomography (CT) angiography on an annual basis is increasing the cost of EVAR, exposing the patient to ionizing radiation and nephrotoxic contrast agent. The mechanism of aneurysm rupture secondary to endoleak is related to a pressurization of the aneurysm sac close to the systemic pressure. There is a relation between sac shrinkage or expansion and sac pressurization. The residual pressurization of AAA will induce sac pulsatility and blood circulation in the sac thus preventing sac thrombosis and aneurysm healing. NIVE using the LSME may become a complementary follow-up imaging technique for EVAR. NIVE has the capability of providing important information on the thrombus organization within the aneurysm sac and on the detection of endoleaks. The characterization of the thrombus organization was not possible in a previous NIVE study. A limitation was the absence of CT examinations as gold standard for endoleak diagnosis. In the current study, we aimed to apply and optimize NIVE of AAA after EVAR with SG in a canine model to detect endoleaks and characterize thrombus organization. SGs were implanted in a group of 18 dogs with an aneurysm created in the abdominal aorta. Type I endoleak was created in 4 aneurysms, type II in 13 aneurysms and no endoleak in 1 aneurysm. DUS and NIVE examinations were performed at baseline, 1-week, 1-month, 3-month and 6-month follow-up after EVAR. Angiography, CT-scan and macroscopic tissue slides were performed at sacrifice. Strain values were computed using the LSME. Areas of endoleak, solid thrombus (organized) and fresh thrombus (non-organized) were identified and segmented by comparing the results of CT scan and macroscopic tissue slides. Strain values in areas with endoleak, organized and fresh thrombi were compared. Strain values were significantly different between endoleak and organized or fresh thrombus areas and between organized and fresh thrombus areas. All endoleaks were clearly characterized on elastography examinations. No correlation was found between strain values and type of endoleak, sac pressure, endoleak size and aneurysm size.

Ces travaux s’inscrivent dans le cadre de la navigation endovasculaire assistée par ordinateur. L’objectif principal est d’étudier et de proposer de nouvelles solutions pour la localisation et le suivi des dispositifs endovasculaires en mouvement par rapport aux structures anatomiques, considérées comme immobiles ou mobiles. Il s’agit à terme de faciliter le geste interventionnel, en maximisant la précision et la fiabilité des procédures, tout en minimisant le recours aux rayons X et au produit de contraste. Les travaux et résultats obtenus concernent : - L’étude d’approches de recalage permettant de fusionner des données 3D pré-opératoires décrivant les structures anatomiques et des données intra-opératoires de localisation 3D électromagnétique (positions d’un cathéter équipé d’un capteur magnétique en son extrémité). Dans le contexte du traitement des anévrismes aortiques abdominaux, deux méthodes de recalage ne nécessitant pas de marqueur externe et exploitant uniquement les trajectoires endovasculaires (avec hypothèse de correspondance totale ou partielle) ont été proposées. Les tests ont été réalisés sur fantôme physique. Bien que la précision de localisation des systèmes électromagnétiques soit encore limitée, ceux-ci pourraient être utilisés pour aider la navigation endovasculaire, comme par exemple, lors du cathétérisme d’artères collatérales. - L’élaboration d’une méthode de tracking des calcifications et de repères dans les séquences d’images fluoroscopiques, dans le contexte des procédures d’implantation endovasculaire de valve aortique (TAVI). Nous avons proposé une méthode de tracking par modèle d’apparence adaptatif (TMAA). L'approche a été évaluée sur 13 séquences fluoroscopiques dans le cadre des procédures TAVI valve native et 5 séquences fluoroscopiques dans le cadre des procédures TAVI valve-in-valve. Elle fournit une erreur de localisation moyenne inférieure à 1 mm et un temps de traitement de 32,23 ms/trame. L’évaluation de cette méthode et son application sur données patients ont permis de montrer la précision et la compatibilité du tracking avec une utilisation clinique. / This work is part of computer-assisted endovascular navigation. The aim of this thesis is to study and to propose new solutions for the localization and the tracking of moving endovascular devices within anatomical structures, which can be considered fixed or moving. The objective is to facilitate the endovascular intervention, by maximizing the accuracy and reliability of procedures, while minimizing the use of X-rays and contrast agents. The works concern : - The study of registration approaches to align pre-operative 3D data describing the anatomical structures and intra-operative 3D electromagnetic data (positions of a catheter equipped with a magnetic sensor at its tip). In the context of the treatment of abdominal aortic aneurysms (AAA), two fiducial-free registration methods that exploit only the endovascular trajectories (with total or partial correspondence hypothesis) have been proposed. The tests were performed on an AAA phantom. Although the localization accuracy of electromagnetic systems is still limited, these could be used to assist endovascular navigation (e.g., catheterization of collateral arteries). - The elaboration of a method to track calcifications and markers in fluoroscopic sequences, in the context of transcatheter aortic valve implantation (TAVI) procedures. We proposed a method of tracking by adaptive appearance model (TMAA). The approach was evaluated on 13 fluoroscopic sequences as part of TAVI native valve procedures and 5 fluoroscopic sequences as part of TAVI valve-in-valve procedures. The average localization error was less than 1 mm and the average processing time was 32.23 ms/frame. The evaluation of this method and its application on patient data has made it possible to show the precision and the compatibility of the tracking with a clinical use.

在現代外科實務中，我們今天認為是標準作業程序的手術，追溯到初期可能是激進創新。多年來，外科技術雖然已經有頻繁的修改，但往往是漸進式地。心臟和血管外科領域中的大多數創新並沒有導致日常實踐劇變。然而，在過去的幾年中，在我服務的醫院和全世界，我看到了治療腹主動脈瘤 (AAA) 的典範轉移，亦即主動脈腔內修復 (EVAR)。 相對於傳統開腹手術修復 （OSR），主動脈腔內修復較傳統開腹手術修復有顯著較低的手術死亡率。不過，長遠來說，總死亡率或動脈瘤相關死亡率並無差異；而主動脈腔內修復有較高的植入物相關併發症和必須再次手術的機率，且成本更高。然而，主動脈腔內修復還是成為腹主動脈瘤治療的支柱。這是為什麼？ 除了是激進的技術創新，主動脈腔內修復也是技術頓悟。傳統上，醫療服務是典型的技術輔助服務情境，其中包含兩個單獨的、然而是密切相關的溝通系統： 一個是產業與醫師之間，另一個是醫師與病人之間。醫師居於樞紐地位，不僅確保治療之執行，而且還要評估結果。由於現代資訊與通信技術的發達，病人可以方便地搜尋輔助醫療文獻資訊、線上資訊和個人社會網絡的意見。這就像是詮釋者的作用。這詮釋者的解釋對病人、外科醫生、和醫療產業界產生了實質上重大的影響，反之亦然。以前在這服務體系中互相分離的部分現在可以緊密地互相配合了，這與服務導向邏輯中價值共同創造的概念是不謀而合的。 總之，對多重利益相關者之意義提升是臨床醫療服務典範轉移的原因。在醫療行業中引入服務導向邏輯的概念的重要性，不論是在日常實務和創新策略上的意義都是不容忽視的。醫療服務中，多重利益相關者比以前更涉及共同創造價值的過程。未來的創新者除了專注在技術和科技上，更必須考慮該創新對多重利益相關者之意義提升。 / In modern surgical practice, what we consider as standard procedures today may be radical innovations dated back to the early days. Over the years, there has been frequent modification of surgical techniques, often incremental though, and most innovations in the field of cardiac and vascular surgery didn’t result in drastic changes in the daily practice. However, during the past several years, I have been witnessing a paradigm shift in the treatment of abdominal aortic aneurysm (AAA) in my hospital and worldwide towards endovascular aortic repair (EVAR). In comparison to the traditional open surgical repair (OSR), EVAR was associated with a significantly lower operative mortality than OSR. However, no differences were seen in total mortality or aneurysm-related mortality in the long term, and EVAR was associated with increased rates of graft-related complications and reinterventions and was more costly. Nevertheless, EVAR is becoming the mainstay of AAA treatment. Why is this? Except for being a radical technology innovation, EVAR is also a technology epiphany. Traditionally, medical service is a typical technology-assisted service encounter, consisting of two separate, however, closely inter-related communication systems: one between the industry and the physician, and the other one between the physician and the patient. The physician is of the pivot role that not only ensures the execution of treatment but also evaluates the results.With modern information and communication technologies, patients caneasily search information from paramedical literatures, online information, and opinions from personal social network. This serves the emerging role of an interpretor. This interpretors’interpretation has substantial influence on patients, surgeons, industry, and payers and vice versa. Previously separated parts in the service system now can be closely inter-related. This is in concordance with the concept of co-creation of value in service-dominant logic. It is concluded that newly defined meanings to multiple stakeholders are the reasons for paradigm shift in clinical medical service. The importance of introduction of the concept of service-dominant logic into the medical industry, both in daily practice and in innovation strategy can never be over-emphasized. Multiple stakeholders are being involved much more than before in the process of co-creation of value in medical service.Future innovators must concentrate on meanings to multiple stakeholders as well on techniques and technologies.

Orientador: Regina Moura / Resumo: A Síndrome de Cockett (SC) se deve a uma compressão extrínseca da veia ilíaca comum esquerda (VICE) pela artéria ilíaca comum direita (AICD). Em consequência há o desenvolvimento de lesões intraluminais. Este cruzamento entre a artéria e a veia é considerada uma condição anatômica usual, porém em cerca de 29% da população ela pode torna-se sintomática. Os sintomas causados pela SC são: edema, dor, claudicação venosa, hiperemia, varizes e úlceras, podendo evoluir também com complicações como trombose venosa, embolia pulmonar, e mais raramente com Flegmasia Cerúlea Dolens. Até hoje não existe consenso sobre a melhor forma de tratar pacientes com SC na presença ou ausência de trombose da VICE, dividindo as opiniões se deve ser feito o tratamento clínico e/ou endovascular. Preferencialmente alguns autores optam pelas técnicas endovasculares em todos os casos e sugerem que a mesma seja realizada, na tentativa de melhorar a fluxo venoso evitando as complicações tardias. Á curto prazo, os resultados do tratamento endovascular com stents, tem mostrado excelente perviedade, embora estejam alguns deles associados ao uso de antiagregantes, anticoagulantes e ao tratamento clinico convencional com a meia elástica. Objetivo: O presente estudo teve a finalidade de comparar os resultados de perviedade e a taxa de complicações ocorridas em pacientes portadores da SC, tratados com angioplastia e stent, na presença e ausência de trombose da VICE, utilizando a Revisão Sistemática e Meta-análise ... (Resumo completo, clicar acesso eletrônico abaixo) / Mestre

Submitted by LENIZE DA SILVA RODRIGUES (nize_silva@hotmail.com) on 2017-09-27T19:16:54Z No. of bitstreams: 1 DISSERTACAO DE MESTRADO PESQUISA CLINICA - LENIZE DA SILVA RODRIGUES.pdf: 2672614 bytes, checksum: 59d7f6f68213dfaccdca11f5c0b0f7bf (MD5) / Approved for entry into archive by Monique Sasaki (sayumi_sasaki@hotmail.com) on 2017-09-28T14:36:32Z (GMT) No. of bitstreams: 1 rodrigues_ls_me_bot.pdf: 2672614 bytes, checksum: 59d7f6f68213dfaccdca11f5c0b0f7bf (MD5) / Made available in DSpace on 2017-09-28T14:36:32Z (GMT). No. of bitstreams: 1 rodrigues_ls_me_bot.pdf: 2672614 bytes, checksum: 59d7f6f68213dfaccdca11f5c0b0f7bf (MD5) Previous issue date: 2017-09-01 / A Síndrome de Cockett (SC) se deve a uma compressão extrínseca da veia ilíaca comum esquerda (VICE) pela artéria ilíaca comum direita (AICD). Em consequência há o desenvolvimento de lesões intraluminais. Este cruzamento entre a artéria e a veia é considerada uma condição anatômica usual, porém em cerca de 29% da população ela pode torna-se sintomática. Os sintomas causados pela SC são: edema, dor, claudicação venosa, hiperemia, varizes e úlceras, podendo evoluir também com complicações como trombose venosa, embolia pulmonar, e mais raramente com Flegmasia Cerúlea Dolens. Até hoje não existe consenso sobre a melhor forma de tratar pacientes com SC na presença ou ausência de trombose da VICE, dividindo as opiniões se deve ser feito o tratamento clínico e/ou endovascular. Preferencialmente alguns autores optam pelas técnicas endovasculares em todos os casos e sugerem que a mesma seja realizada, na tentativa de melhorar a fluxo venoso evitando as complicações tardias. Á curto prazo, os resultados do tratamento endovascular com stents, tem mostrado excelente perviedade, embora estejam alguns deles associados ao uso de antiagregantes, anticoagulantes e ao tratamento clinico convencional com a meia elástica. Objetivo: O presente estudo teve a finalidade de comparar os resultados de perviedade e a taxa de complicações ocorridas em pacientes portadores da SC, tratados com angioplastia e stent, na presença e ausência de trombose da VICE, utilizando a Revisão Sistemática e Meta-análise de estudos observacionais. Método: Foram utilizadas as recomendações do manual Cochrane Handbook for Intervention Reviews produzido pela Cochrane que orienta a produção de revisões sistemáticas utilizando como referência para a escolha do método. A produção desta dissertação e manuscrito foi baseada no MOOSE statement para garantir que todas as etapas do estudo sejam reportadas claramente. As bases de dados utilizadas foram: Medline, EMBASE, LILACS, Scopus, Scielo, Pubmed e, Web of Science. A data da última busca foi 06 de abril de 2017. Esta pesquisa incluiu estudo de 2 grupos principais, tratados com angioplastia e stent: no G1: foram incluídos pacientes com a SC ausência trombose VICE e no G2 foram incluídos pacientes com SC presença de trombose da VICE. Resultados: De 250 artigos foram selecionados 3 estudos comparativos observacionais, sendo o número total de pacientes avaliados igual a 243. Nestes trabalhos selecionados foram associados ao tratamento endovascular o uso de antiagregantes plaquetários, anticoagulantes durante o período 3 a 12 meses e o uso da meia elástica. A patência primária, respectivamente, no G1 e G2 foi de e 93,4% e 89,2% (OR 0.55, 95% IC [0.15, 2.06], P= 0.37; I2=29%, P=0.24). E a patência secundária, respectivamente, de G1 e G2 foi de 93.5% e 82.06% (OR 0.50, 95% IC [0.05, 4.72], P= 0.54; I2=69%, P=0.04). Embora não estatisticamente significante, observa-se uma tendência em ocorrer maior patência nos pacientes do G1. Em relação ás complicações no total, houve tendência maior no G2 em relação ao G1. Conclusão: Os resultados obtidos neste estudo de revisão sistemática, mostraram que o tratamento endovascular é eficaz em ambos os grupos à curto prazo e longo prazo, mas, sugere que no grupo 1 a perviedade é discretamente melhor que no grupo 2, com menores complicações. / The Cockett Syndrome (CS) is due to an extrinsic compression of the common left iliac vein (CLIV) by the common right iliac artery (CRIA). Consequently, there is a development of intraluminal lesions. This crossing between the artery and the vein is considered a usual anatomic condition; however, in about 29% of the population it may become symptomatic. The symptoms caused by the CS are: edema, pain, venous claudication, hyperemia, varicose veins e ulcers, being possible also to evolve with complications such as venous thrombosis, pulmonary emboli and more rarely with Flegmasia Cerúlea Dolens. Until today there´s no consensus about the best way to treat patients with CS in either the presence or the absence of CLIV thrombosis, it has been dividing opinions whether the clinical or the endovascular treatment should be done. Preferably, some authors choose the endovascular techniques in all cases and suggest that it be performed, in the attempt of improving the venous flow thus avoiding later complications. In short term the results of the endovascular treatment with stents, have shown excellent patency, although some of them are associated to the use of antiplatelet, anticoagulants and to the conventional clinical treatment with compression stocking. Objective: the present study had as goal to compare the results of the patency and the complication rate occurred in patients bearing the CS, treated with angioplasty and stent, in the presence and absence of the CLIV thrombosis, using the Systematic Review and Meta-Analysis in the observational studies. Method: It has been used the recommendations of the manual Cochrane Handbook for Intervention Reviews which orients the production of systematic reviews using as reference for the choice of the method. The production if this dissertation and manuscript has been based on the MOOSE statement to assure that all phases of the study be reported with clarity. The data bases used were: Medline, EMBASE, LILACS, Scopus, Scielo, Pubmed and, Web of Science. The date of the last search was April 6th 2017. This research includes the study of two main groups, both treated with angioplasty and stent: in the G1: it has been included patients with CS without CLIV thrombosis and in the G2: it has been included patients showing CS without CLIV thrombosis. Results: From 250 articles, it has been selected three comparative observational studies, being the total number of analyzed patients equal to 243. In these selected works it has been associated the use of antiplatelet, anticoagulants during the period from 3 to 12 months and the use of the compression stocking. The primary patency, respectively, in G1 and G2 has been of 93.4% and 89.2% (OR 0.55 (95% IC [0.15, 2.06], P= 0.374; I2=29%, P=0.24). And the secondary patency, respectively, in G1 and G2 has been of 93.5% and 82.06% (OR 0.50, 95% IC [0.05, 4.72], P= 0.54; I2=69%, P=0.04). Even though statistically not relevant in both patencies, it can be observed a tendency in the occurrence of a greater patency in patients from G1. In relation to the complications in the total, there has been difference being greater G2 in relation to the G1. Conclusion: The results obtained in the study of systematic review, have shown that the endovascular treatment is effective in short and long terms, but it suggests that in group 1 the patency is discreetly greater than in group 2, with less complications.